Neurothera Labs Inc (NTLX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 01/31
(Values in thousands)
| 10-2021 | 07-2021 | 04-2021 | |
| Cost of Goods | 0 | 20 | N/A |
| Gross Profit | 0 | -20 | N/A |
| Operating Expenses | 41 | 38 | 14 |
| Operating Income | -41 | -58 | -14 |
| Pre-tax Income | -41 | -58 | -15 |
| Net Income Continuous | -41 | -58 | -15 |
| Net Income | $-41 | $-58 | $-15 |
| EPS Basic Total Ops | -0.01 | -0.02 | 0.00 |
| EPS Basic Continuous Ops | -0.01 | -0.02 | N/A |
| EPS Diluted Total Ops | -0.01 | -0.02 | 0.00 |
| EPS Diluted Continuous Ops | -0.01 | -0.02 | N/A |
| EBITDA(a) | $-41 | $-58 | $-14 |